Aerobic Capacity Clinical Trial
Official title:
Randomized, Parallel, Double-blind, Placebo Controlled, Study in Men to Assess the Influence of Aronox on Parameters Associated With Aerobic Performance
A randomized, double blind, counterbalanced, placebo controlled independent groups design. Participants will then be familiarized with the ergometer to determine settings and seating position and randomized to an investigational product group (2 groups: Aronox vs placebo; 1:1 allocation). A time to undergo baseline testing will then be scheduled (day 0). On the baseline day, stature, body mass, blood pressure and heart rate will be assessed. Participants will then complete a submaximal aerobic performance test (lactate profile) where expired gas, heart rate, blood lactate,and RPE will be measured. Following a 10-min rest, participants will then perform a ramp test to exhaustion to determine VO2max (this will be to finalize eligibility to the study - VO2max of 45-70 ml/kg/min). Expired gas, heart rate, power output, perceived exertion, and near-infra-red spectroscopy will be collected throughout and blood lactate will be determined at test termination. Those that do not fulfill the criteria for VO2max will be excluded from the study at this point. Those that are eligible (verified by their VO2max) will consume a standardized 'light' meal and rest for 2 h. Time to exhaustion (TTE) trial (60%GET) determined from previous tests (lactate profile and VO2max) will then be completed. On completion of the TTE trial, the first dose of the investigational product will be administered in the laboratory and participants will be given a 4-week supply of the investigational product to take in the morning with breakfast. Participants will also be given study diaries to complete (exercise, general health, dietary intake). On the final study day (day 28), remaining investigational capsules and study diaries will be collected to monitor compliance. An identical trial to day 0 will then be conducted, following which participants will be asked if they knew what supplement they were asked to consume and be given the chance to provide feedback on their experience.
Prior to the visit, participants will be issued with a participant information sheet to
inform of the procedure and study requirements,then undergo initial screening via email or
telephone to ascertain suitability to participate. If interested parties wish to participate,
then an invitation for a familiarisation visit will be made, where they will:
Be provided with an overview of the protocol and given the opportunity to ask questions
Complete a health and physical activity questionnaire to ascertain study suitability Complete
a training status questionnaire Assessment of ability to swallow capsules Complete an
informed consent to participate in the study (assuming they meet the criteria and are willing
to participate)
Exercise protocol details During the first and second visit to the laboratory, participants
will complete cycling tests; a submaximal exercise test and an incremental ramp exercise test
to exhaustion to elucidate maximal aerobic power (Wmax), VO2max and gas exchange threshold
(GET); both tests will be completed using an electro-magnetically braked cycle ergometer. The
submaximal test will require participants to begin cycling at 100 W, which will increase by
25 W every minutes. Heart rate and capillary blood samples will taken from the earlobe in the
last 30 s of each stage and immediately analysed for blood lactate concentration. Cycling
will be terminated when the lactate turn-point had been reached. Throughout the submaximal
test, near-infra-red spectroscopy (NIRS) and pulmonary gas exchange will be monitored through
an online gas analysis system. Gas data will be averaged over the final 30 s of each stage in
order to analyse the O2 cost. Following the completion of the submaximal test, participants
will be given 10 minutes rest prior to completing the incremental ramp test to exhaustion to
determine VO2max. The ramp test will consisted of 3 minutes of cycling at 100 W, followed by
an increase in work rate of 1 W every 3 seconds (20 W.min-1) until the participant reaches
volitional exhaustion or the cadence drops 10 rpm below the preferred cadence.
Breath-by-breath pulmonary gas exchange data will collected throughout the ramp protocol and
VO2max will be calculated as the highest 30-second average in oxygen consumption. Using the
regression equation calculated from the submaximal VO2 data and the VO2max, it will then
possible to identify the power output associated with the GET. The GET will be determined
using either the first disproportionate increase in CO2 production (VCO2) from visual
inspection of individual plots of VCO2 vs. VO2 or an increase in expired ventilatory
equivalents (VE/VO2 with no increase in VE/VCO2). Following a standardized meal during a rest
period of ~2 h, a time to exhaustion (TTE) test will be completed to examine exercise
tolerance. The intensity for TTE test will be 60% of the difference between GET and VO2max.
Saddle, handlebar height and fore/aft position was recorded and replicated on the return
laboratory visit following supplementation.
Standardized meal Descriptive measures and a Physical Activity Level (PAL) of 1.7 will be
used to calculate the participant's individual resting energy expenditure. This will
subsequently identify the amount of cereal (Rice Snaps, Tesco, Manchester, UK) and
semi-skimmed milk (1g/kg/bm) each individual will need to consume to meet 10% of their daily
energy requirements (DER). This standardized fixed-energy breakfast meal will consist of a
cereal: milk ratio of 30 g: 120 mL and will deliver fat, protein and carbohydrate with a
macronutrient composition of 14, 14 & 72%, respectively.
Supplementation Following group allocation, participants will be provided with aronia
(Aronox®) or placebo (PLA) supplementation and instructed to consume 500mg of the
investigational product with breakfast every day for 4 weeks.
Data Analysis:
Statistical analysis will be performed using PASW Statistics 21.0 for Windows (SPSS, Inc.,
Chicago, IL.). All group characteristics will be reported as means ± standard errors, unless
otherwise stated. A two-way ANOVA tests will be used to allow for comparison of between- and
within- group mean differences for each dependent variable. Appropriate post-hoc analysis
will be performed to determine any location of significance. Mauchley's test will
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05444959 -
The Impact of Exercise / Stress Stimuli on HMB Supplementation Efficacy
|
Phase 2/Phase 3 | |
Recruiting |
NCT05743673 -
SHAPE Test for Preoperative Risk Stratification
|
||
Completed |
NCT06390670 -
The Effect of Colostrum Bovinum Supplementation in Endurance Athletes
|
Phase 2/Phase 3 | |
Completed |
NCT06186297 -
Boosting Performance: The Power of Cranberry Supplementation
|
N/A | |
Completed |
NCT02604147 -
Inspiratory Muscle Training in Wheelchair Basketball Players
|
N/A | |
Completed |
NCT03752060 -
The Clinical Utility of Resistance Training for Improving Cardiovascular Disease Risk in Post-Menopausal Women
|
N/A | |
Recruiting |
NCT05496777 -
Home-based Prehabilitation in Pancreatic Resection
|
N/A | |
Completed |
NCT05218798 -
Enhancement of Physical and Combat Preparedness of SAF Members - Validation Study
|
N/A |